Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder.
- DOI
- 10.1111/cns.13731
- Published
- 2021 Dec
- Container
- CNS neuroscience & therapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cns.13731,
title = {Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder.},
author = {Abdallah MS and Ramadan AN and Omara-Reda H and Mansour NO and Elsokary MA and Elsawah HK and Zaki SA and Abo Mansour HE and Mosalam EM},
year = {2021},
journal = {CNS neuroscience \& therapeutics},
doi = {10.1111/cns.13731},
url = {https://doi.org/10.1111/cns.13731}
}RIS
TY - JOUR TI - Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder. AU - Abdallah MS AU - Ramadan AN AU - Omara-Reda H AU - Mansour NO AU - Elsokary MA AU - Elsawah HK AU - Zaki SA AU - Abo Mansour HE AU - Mosalam EM PY - 2021 JO - CNS neuroscience & therapeutics DO - 10.1111/cns.13731 UR - https://doi.org/10.1111/cns.13731 ER -
APA
MS, A., AN, R., H, O., NO, M., MA, E., HK, E., SA, Z., HE, A. M., & EM, M. (2021). Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder.. CNS neuroscience & therapeutics. https://doi.org/10.1111/cns.13731
Source records
- pubmed · retrieved 2026-09-24T20:58:12.706Z